Featured Story The PSMA-Targeting Era: A Game-Changer for Men with Prostate Cancer Worldwide
Martin Pomper’s team developed a radioactive tracer, recently FDA-approved, that can show tiny bits of prostate cancer as small as a grain of rice.
Winter 2022
A Publication of the Patrick C. Walsh Prostate Cancer Research Fund
